THE ROCKEFELLER UNIVERSITY

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 143118
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9178
 
  
 
C07K PEPTIDES 7861
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 44162
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 4158
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3293
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 2277
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1877
 
  
 
C07D HETEROCYCLIC COMPOUNDS 17145
 
  
 
H01J ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS 8120

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0051,087 Anti-Inflammatory PolypeptidesMar 04, 16Feb 22, 18[A61K, C07K]
2017/0320,935 Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsJun 21, 17Nov 09, 17[A61K, C12P, G01N, C07K]
2017/0306,346 IMPROVED AGRONOMIC CHARACTERISTICS UNDER WATER LIMITING CONDITIONS FOR PLANTS EXPRESSING PUB10 POLYPEPTIDESNov 10, 15Oct 26, 17[C12N, A01H, C07K]
2017/0283,492 Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsJun 21, 17Oct 05, 17[C07K]
2017/0253,659 ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITYJun 28, 16Sep 07, 17[C07K]
2017/0247,463 Modulating Agonistic TNFR AntibodiesFeb 06, 17Aug 31, 17[C07K]
2017/0218,050 Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsApr 20, 17Aug 03, 17[C07K]
2017/0210,786 Combination of Broadly Neutralizing HIV Antibodies and Viral InducersJul 21, 15Jul 27, 17[A61K, C07K]
2017/0175,142 CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTSJul 22, 16Jun 22, 17[C12N]
2016/0317,677 DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF THE CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR HBV AND VIRAL DISEASES AND DISORDERSJun 10, 16Nov 03, 16[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9914915 bacteriophage lysins for detection and treatment of gram positive bacteriaApr 14, 15Mar 13, 18[A61K, C12N]
9914916 Dimeric bacteriophage lysinsJan 27, 16Mar 13, 18[A61K, C07H, A01N, C12N, C07K]
9890207 Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120Jul 25, 12Feb 13, 18[C07K]
9879068 Antibodies targeting HIV escape mutantsJun 21, 13Jan 30, 18[A61K, C07K]
9845358 Anti-inflammatory polypeptidesMar 04, 15Dec 19, 17[A61K, C07K]
9840533 Compositions and methods for altering second messenger signalingApr 29, 14Dec 12, 17[C07H, A61K, C12Q, C07F, G06F, G06K]
9833465 Anticancer agents of the anthracyclin familySep 26, 16Dec 05, 17[C07H, A61K]
9822372 CRISPR-Cas component systems, methods and compositions for sequence manipulationJan 07, 16Nov 21, 17[C12Q, C12P, C12N]
9816096 Methods and compositions for translational profiling and molecular phenotypingNov 25, 14Nov 14, 17[C12N, G01N, A01K]
9790276 Glycan-modified anti-CD4 antibodies for HIV prevention and therapyDec 18, 13Oct 17, 17[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0088,608 Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsAbandonedOct 07, 16Mar 30, 17[C07K]
2016/0251,720 MicroRNA PROFILES IN HEART FAILURE: METHODS AND SYSTEMS FOR DETECTION AND USEAbandonedNov 03, 14Sep 01, 16[C12Q, C12N]
2016/0115,489 CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATIONAbandonedJan 08, 16Apr 28, 16[C12N]
2016/0115,494 TRANSCRIPTIONAL GENE ACTIVATIONAbandonedOct 27, 14Apr 28, 16[C12N, A01H]
2015/0329,860 GENE SILENCINGAbandonedDec 17, 13Nov 19, 15[C12N, A01G]
2015/0306,139 ANTI-INFLAMMATORY AGENTSAbandonedApr 11, 12Oct 29, 15[A61K, C12Q, C12N, G01N, C07K]
2015/0252,375 TRANSCRIPTIONAL GENE SILENCING OF ENDOGENES IN PLANTSAbandonedAug 27, 13Sep 10, 15[C12N]
2015/0250,726 Nanoscale Bound Bilayers, Methods of Use and ProductionAbandonedMar 20, 15Sep 10, 15[A61K]
2015/0184,139 CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTSAbandonedJul 07, 14Jul 02, 15[C12N]
2015/0159,157 MicroRNAsAbandonedFeb 20, 15Jun 11, 15[C12N]
2015/0031,134 CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATIONAbandonedSep 26, 14Jan 29, 15[C12N]
2014/0323,696 Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsAbandonedMay 16, 14Oct 30, 14[C12P, G01N, C07K]
2014/0186,378 GLYCOLIPIDS AND ANALOGUES THEREOF AS ANTIGENS FOR NKT CELLSAbandonedOct 22, 13Jul 03, 14[C07H, A61K]
2014/0189,896 CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATIONAbandonedDec 12, 13Jul 03, 14[C12N]
2014/0179,594 STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR TREATMENT OF GRAM POSITIVE BACTERIA IN COMPANION ANIMALS AND LIVESTOCKAbandonedApr 20, 12Jun 26, 14[A61K]
2014/0107,104 COMBINATION MEDICINE FOR TREATMENT OF DEPRESSIONAbandonedMar 22, 12Apr 17, 14[A61K, C12Q, G01N]
2014/0073,639 INHIBITION OF ANTIMICROBIAL TARGETS WITH REDUCED POTENTIAL FOR RESISTANCEAbandonedAug 08, 13Mar 13, 14[C12Q, C07D]
2014/0073,684 CHEMICALLY MODIFIED OLIGONUCLEOTIDES FOR USE IN MODULATING MICRO RNA AND USES THEREOFAbandonedAug 27, 13Mar 13, 14[C12N]
2014/0039,803 Method for Rapid Identification of Drug Targets and Drug Mechanisms of Action in Human CellsAbandonedMar 02, 12Feb 06, 14[C12Q, G06F]
8637024 Fusion antibodies for HIV therapyExpiredNov 11, 11Jan 28, 14[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.